CN Patent

CN120860019A — 氯苯唑酸在激活rxr活性中的用途

Assigned to Xiamen University · Expires 2025-10-31 · 1y expired

What this patent protects

在本发明公开了一种式(I)所示的化合物或其互变异构体、立体异构体、溶剂化物、或药学上可接受的盐在制备药物中的用途，所述药物用于预防和/或治疗类视黄醇X受体(RetinoidX receptor,RXR)介导的相关疾病。式(I)所示的化合物可以与RXR结合，有效调节RXR活性，可有效预防和/或治疗RXR相关的疾病。

USPTO Abstract

在本发明公开了一种式(I)所示的化合物或其互变异构体、立体异构体、溶剂化物、或药学上可接受的盐在制备药物中的用途，所述药物用于预防和/或治疗类视黄醇X受体(RetinoidX receptor,RXR)介导的相关疾病。式(I)所示的化合物可以与RXR结合，有效调节RXR活性，可有效预防和/或治疗RXR相关的疾病。

Drugs covered by this patent

acoramidis-hydrochloride (ACORAMIDIS HYDROCHLORIDE)

Patent Metadata

Patent number: CN120860019A
Jurisdiction: CN
Classification: —
Expires: 2025-10-31
Drug substance claim: No
Drug product claim: No
Assignee: Xiamen University
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.